16
Sep
Sep
The new study conducted by researchers from Mass General Brigham states that the addition of new drugs for slimming GLP-1 semaglutide and tirzepatid to ordinary care is a profitable treatment strategy for people with osteoarthritis and knee obesity, with tirrzeepatide, with a lower health benefit with lower costs compared to the semaglutin. Research occurs when […]